Deutsche Bank raised the firm’s price target on UnitedHealth (UNH) to $625 from $595 and keeps a Buy rating on the shares ahead of Wednesday’s investor conference. The firm believes investor positioning into the event is mostly neutral to positive, with almost no one expecting a negative revision versus the Q3 outlook. Deutsche increased the price target multiple one turn to reflect the recent re-rating of the stock on an improve managed care outlook post the election.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- CMS raises MA star ratings for UnitedHealthcare, Centene, MH reports
- Dell and HP forecasts spark selloffs: Morning Buzz
- UnitedHealth pays own physician groups more than others, STAT reports
- UnitedHealth price target raised to $655 from $603 at Barclays
- RBC sees little cause for concern over CMS’ proposed part D GLP-1 coverage rule